Reenav Pharma Private Limited

Reenav Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999MH2018PTC308208 Incorporated 18 April 2018 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2025
₹2.22 Cr
▲ 9% YoY
Net profit · FY 2025
₹12.7 Lakh
Net margin 5.7%
EBITDA · FY 2025
₹27.4 Lakh
EBITDA margin 12.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Reenav Pharma Private Limited

Data last updated:

Reenav Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ascent Wellness And Pharma Solutions Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 April 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC308208. Its GSTIN is 27AAICR8983Q1Z4 (Maharashtra).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Arvind Govind Varia and Rajeshree Trikamlal Gor.

Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 607 6th Floor Skyline Epitome Building Near Jolly Gymkhana Vidyavihar West, Mumbai, Maharashtra, India – 400086.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.22 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹12.7 Lakh (net margin 5.7%) and EBITDA of ₹27.4 Lakh (EBITDA margin 12.4%). Revenue has declined at a compounded annual rate (CAGR) of 78% over three years and 50% over five years.

Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 5 deals on record (4 secondary share transfers, 1 debt financing), with disclosed funding of ₹1.2 Cr; the latest was in August 2020. Its 10 peer companies in the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 5 smaller; the largest is Negbuy Private Limited with revenue of ₹2.22 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2020, listing 52 overdue payments to 1 micro and small supplier.

For more details, the company can be reached via its website reenavpharma.com.

Company details

CIN U74999MH2018PTC308208
Registration Number 308208
Incorporation Date 18 April 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Parent Company Ascent Wellness And Pharma Solutions Private Limited

Contact details

Reenav Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is reenavpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    607 6th Floor Skyline Epitome Building Near Jolly Gymkhana Vidyavihar West, Mumbai, Maharashtra, India – 400086
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Reenav Pharma Private Limited, buy the company report.

Comprehensive company report
Reenav Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Reenav Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Reenav Pharma Private Limited, buy the company report.

Financials of Reenav Pharma Private Limited

FY 2024 filings available

Reenav Pharma Private Limited reported revenue of ₹2.22 Cr (up 9% YoY) for FY 2025.

Revenue · FY 2025
₹2.22 Cr ▲ 9%
Net profit · FY 2025
₹12.7 Lakh margin 5.7%
EBITDA · FY 2025
₹27.4 Lakh margin 12.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 78%
5 years · compounded
▼ 50%
EBITDA CAGR growth
1 year
▲ 226%
3 years · compounded
▼ 43%
5 years · compounded
▼ 11%

Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 50%. EBITDA rose 226% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹27.4 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹12.7 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin12.4%
Net Profit Margin5.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Reenav Pharma Private Limited, buy the company report.

Board of directors of Reenav Pharma Private Limited

Reenav Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arvind Govind VariaDirector18 Apr 20188 Years 7 MonthsCurrent
Rajeshree Trikamlal GorDirector18 Apr 20188 Years 7 MonthsCurrent

Peer comparison

Reenav Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Negbuy Private Limited₹2.22 Cr (FY 2025)-68.0%Delhi, India
Shivshakti Agencies Private Limited₹2.22 Cr (FY 2024)8.0%Uluberia, West Bengal, India
MTC Disposable Eco Products Private Limited₹2.22 Cr (FY 2024)-23.0%Surat, Gujarat, India
Hemalite Products Private Limited₹2.22 Cr (FY 2016)27.0%Chennai, Tamil Nadu, India
Sisumara Trading Private Limited₹2.22 Cr (FY 2018)Kolkata, West Bengal, India
Reenav Pharma Private Limitedthis company₹2.22 Cr (FY 2025)₹12.7 Lakh5.7%9.0%Mumbai, Maharashtra, India
Opus Innovation Private Limited₹2.21 Cr (FY 2024)69.0%Mumbai, Maharashtra, India
Rd Strategic Esales Private Limited₹2.21 Cr (FY 2017)-8.0%Mumbai, Maharashtra, India
Avigenix Innovations Private Limited₹2.21 Cr (FY 2024)57.0%Kolkata, West Bengal, India
Kokane Farmer Producer Company Limited₹2.21 Cr (FY 2025)177.0%Nanded, Maharashtra, India
Richa Paints and Stones Private Limited₹2.21 Cr (FY 2025)-4.0%Kota, Rajasthan, India

To see the full peer comparison of Reenav Pharma Private Limited, buy the company report.

Auditor

Reenav Pharma Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Price Waterhouse Chartered Accountants LLPFY 2023012754N/N500016

Shareholding

The shareholding of Reenav Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Reenav Pharma Private Limited, buy the company report.

Deals & funding

Reenav Pharma Private Limited has 5 deals on record (4 secondary share transfers, 1 debt financing), with disclosed funding of ₹1.2 Cr; the latest was in August 2020.

Total deals
5
Secondary share transfers
4
Debt financing
1
Disclosed funding
₹1.2 Cr

Deals on record (5 of 5)

WhenDealAmountParties
Aug 2020Secondary share transferUndisclosedBuyer: Ascent Wellness and Pharma Solutions Private Limited
Seller: Api Holdings Limited
Aug 2020Secondary share transferUndisclosedBuyer: Api Holdings Limited
Seller: Ascent Health and Wellness Solutions Private Limited
Mar 2019Secondary share transferUndisclosedBuyer: Ascent Health and Wellness Solutions Private Limited
Seller: 2 individuals
Nov 2018Debt financing₹1.2 CrInvestors: Ascent Health and Wellness Solutions Private Limited
Oct 2018Secondary share transferUndisclosedBuyer: Ascent Health and Wellness Solutions Private Limited
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Reenav Pharma Private Limited has 4 MSME Form 1 returns on record between 2019 and 2020, listing 52 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
Miraclus Orthotech Private Limited

To see the full MSME payment records of Reenav Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Reenav Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAICR8983Q1Z4MaharashtraActive28 Jun 2018

To see the full GST registrations and return filing status of Reenav Pharma Private Limited, buy the company report.

Recent activity

Reenav Pharma Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Anand Subramanian Iyer ceased to be Additional Director on 24 Sep 2022.

AGM
Reenav Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records.
Filing
Reenav Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Anand Subramanian Iyer ceased to be Additional Director.
Ceased
Kalpana Srinivasan ceased to be Additional Director.
Ceased
Jay Rajesh Mehta ceased to be Director.
Appointed
Arvind Govind Varia was appointed as Director.
Appointed
Rajeshree Trikamlal Gor was appointed as Director.
Incorporation
18 Apr 2018
Reenav Pharma Private Limited was registered on 18 Apr 2018 with Roc Mumbai & aged 8 years 7 months as per MCA records.

Frequently asked questions

Reenav Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 April 2018 (8+ years old) and is registered under CIN U74999MH2018PTC308208.

Reenav Pharma has 2 current directors:

The latest financial statements of Reenav Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Reenav Pharma is 27AAICR8983Q1Z4, registered in Maharashtra.

The CIN (Corporate Identification Number) of Reenav Pharma is U74999MH2018PTC308208. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Reenav Pharma has 1 court case on record: 1 filed by the company. 1 is pending.

Reenav Pharma was incorporated on 18 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.

Reenav Pharma has 5 deals on record (4 secondary share transfers, 1 debt financing), with disclosed funding of ₹1.2 Cr; the latest was in August 2020.

The peers of Reenav Pharma by revenue are Negbuy Private Limited, Shivshakti Agencies Private Limited, MTC Disposable Eco Products Private Limited, Hemalite Products Private Limited, Sisumara Trading Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Anand Subramanian Iyer ceased to be Additional Director on 24 Sep 2022. Kalpana Srinivasan ceased to be Additional Director on 24 Sep 2022. Jay Rajesh Mehta ceased to be Director on 13 May 2022. Reenav Pharma has 5 board changes on record in total.

Reenav Pharma has 4 MSME Form 1 returns on record between 2019 and 2020, listing 52 overdue payments to 1 micro and small supplier. The latest return was filed on 30 Jan 2021.

Reenav Pharma can be reached through the website reenavpharma.com. Its registered office is in Mumbai, Maharashtra, India.